Professor Frédéric Amant, PhD and MD, received his medical degree from the University of Leuven (KU Leuven), Belgium in 1992, completed his specialty training as an obstetrician/gynecologist in 1998, and his subspecialty training in gynecologic oncology in 2000.
He is professor at the KU Leuven, Belgium, and a specialist in gynecologic oncology at the University Hospitals Leuven (UZ Gasthuisberg), Belgium and at Antoni van Leeuwenhoek – Netherlands Cancer Institute (Center for Gynecologic Oncology Amsterdam). At KU Leuven he heads the scientific section of this specialty.
Professor Amant is an author on more than 400 peer-reviewed scientific papers, has contributed to 20 books and is a highly sought-after guest lecturer worldwide. He chairs the Endometrium Tumor Site Committee of the European Organization for Research and Treatment of Cancer (EORTC), Gynecologic Cancer Group. He chairs the European Network for Individualized Treatment of Endometrial Cancer (ENITEC), a task force within the European Society of Gynecologic Oncology (ESGO). Professor Amant also heads the International Network on Cancer, Infertility and Pregnancy (INCIP), also within ESGO, and is recognized as a world authority on the topic cancer in pregnancy. Furthermore, he chairs the Patient Derived Tumor Xenograft Platform (Trace) at KU Leuven and is a member of the European consortium on xenografts EurOPDX.